Inhalation Digital Issue Now Available
photoNew at Drug Delivery to the Lungs (DDL) 2018
Drug Delivery to the Lungs (DDL) 2018 will be held December 12-14 at the Edinburgh International Conference Center in Edinburgh, UK. As of October 17, the following companies, who have recently advertised in Inhalation, were listed on the conference website as exhibitors. Additional exhibitors are added continually. Content is provided by the companies listed. No product endorsement or preference is intended.
Aptar Pharma
As a leader in respiratory drug delivery systems, Aptar Pharma is focused on supporting customers and patients to effectively treat respiratory diseases including asthma and COPD. At DDL 2018, Aptar Pharma will showcase its broad respiratory drug delivery portfolio of MDIs, DPIs and BAIs, including its growing range of connected devices. Available as either add-on or fully integrated, our
c-devices can deliver better patient health outcomes through improved adherence.
France: +33 1 39 17 20 20
Astech Projects, Ltd.
Astech Projects specializes in the supply of automated inhaler testing solutions for all device types including DPI, MDI and BAI. Astech's award-winning X-Products® range, which includes Xelair®, Xelize® and Xelox®, provides robust, durable and consistent testing for Dose Content Uniformity (DCU) and Particle Size Determination (PSD) including Andersen and NGI Impactors. Custom automated solutions are available for waste firing, physical device testing, emitted dose weight, vision and inspection. Astech also offers a comprehensive maintenance and support service called REACTS®, providing peace of mind for the lifetime of a system.
UK: +44 1928 571797
At DDL 2018, Catalent will be showcasing its solutions for the development of inhalation and nasal drug products. Catalent leverages decades of experience in formulation, particle size engineering and manufacturing to accelerate and advance molecules and development programs across multiple dosage forms. Catalent's inhalation manufacturing operations have a track record of regulatory excellence and the company manufactures MDIs, DPIs and nasal formulations for customers around the globe.
Copley Scientific
With over 25 years' presence at DDL conferences, Copley Scientific will once again be sponsoring DDL 2018. Our experts from the UK, China and Switzerland will be present to meet and discuss your inhaler testing needs. This year's highlight will be the Breath Actuation Controller BAC™ 2100, featuring the MDI Actuation Sensor. The system allows for coordination of device actuation and flow, as well as volume control for MDI testing, including MDIs that have add-on devices or are breath-actuated. Advanced features include fully automated in situ cascade impactor leak testing and extensive data reporting capabilities.
UK: +44 1159 616229
Containment Technology Services
CTS Europe will exhibit at DDL again and we look forward to meeting our customers and friends in the Inhalation sector. We will have our industry-approved ClimateZone system available for demonstrations. The system provides a climatic-controlled environment for handling inhalation products and carrying out inhalation tests.
UK: +44 2392 695521
Gateway Analytical
Gateway Analytical provides industry-leading pharmaceutical analysis services tailored to support your drug product development needs. Our expert team of materials-characterisation specialists can help you solve a broad range of technical challenges, from reference product deconstruction through in vitro bioequivalence and batch release testing. Our labs are fully cGMP complaint and ISO 9001 & 17025 accredited. Please join us at our booth, where we'd be happy to discuss how we can help with your specific development challenges.
US: +1 724 443-1900
H&T Presspart
H&T Presspart offers a unique plasma process—manufactured under license from Portal Medical, Ltd.—for treating the internal surfaces of metered dose inhaler (MDI) canisters, which ensures the active drug content does not stick to the canister wall. This solves a problem present in many other MDI canisters and helps ensure the patient receives the correct dose.
UK: +44 1254 584131
Hovione offers development and compliant manufacture of innovative new drugs and niche generic active pharmaceutical ingredient (API) products. Hovione also supports highly potent compounds and offers proprietary product development and licensing opportunities for drug products. The company undertakes formulation development and clinical supply of final dosage forms to Phase II. With strong expertise in pulmonary delivery, Hovione offers APIs for inhalation, DPI devices, particle engineering and formulation development.
Portugal: +351 21 982 9000
Strong bioperformance of your inhaled therapeutics is key to realizing optimal patient outcomes. Lonza Pharma & Biotech supports you in optimizing performance and leveraging unique capabilities as well as with expertise in product design and particle engineering. You gain access to a large array of specialized tools, including micronization, spray dry processing and nanocrystal technologies. Combined with formulation expertise for both small and large molecules, specialized DPI capsules and finished product manufacturing capabilities to commercial scale, we bring your product from concept to market.
US: +1 888 783-6361
Meggle Excipients
& Technology
Meggle's new InhaLac® 160 lactose for dry powder inhalation is characterized by a median particle size of approximately 110 µm, which ranges between Meggle's coarser lactose InhaLac® 120 and the finer lactose InhaLac® 230. Benefits of InhaLac include a dedicated production process and highly controlled powder characteristics.
Germany: +49 08071 73 476
Merxin is a generic device supplier. We develop and provide inhalers that have popular device platforms so you can speed up product development and filing, reduce cost, reduce risk and increase success. The Merxin MRX001 is a multidose blister dry powder inhaler (DPI), MRX003 is a capsule DPI and MRX004 is a soft mist inhaler.
UK: +44 1223 787300
Newtec specializes in the design, development, manufacturing and supply of medical plastic devices and components, primarily in the field of respiratory and pulmonary drug delivery, notably MDI actuators and dose-counting actuators. Newtec also works one-on-one with pharmaceutical companies to meet their specific product development requirements, providing innovation, customization and development services.
India: +91 22 28509138
Next Breath
Next Breath is a full-service, cGMP-compliant laboratory specializing in the analytical testing of drug delivery systems. We provide comprehensive solutions for the product development process, from formulation and CMC support to finished batch release and post-approval stability studies.
US: +1 410 455-5904
Proveris Scientific
Proveris Scientific delivers innovative technologies, services and deep product knowledge to a worldwide customer base that produces pulmonary and nasal drug products. Our team of experts has helped the industry enable the rapid commercialization of spray and aerosol therapies by simplifying the complex relationships between formulation, patient and device. At DDL 2018, learn about our DPI and BAI characterization studies and new instruments offered to seamlessly integrate consistent actuation parameters into the entire pMDI testing workflow.
US: +1 508 460-8822
Recipharm will be highlighting its expanded development and manufacturing capabilities for novel respiratory products at DDL2018. The CDMO recently acquired Sanofi's Holmes Chapel, UK site, which specializes in the manufacture of metered dose inhalers and nasal sprays and complements the inhalation development expertise offered by Recipharm in Research Triangle Park, North Carolina. The CDMO has expertise in drug substance production through formulation and delivery device development, analytical testing and cGMP commercial-scale manufacturing.
Sweden: + 46 8 602 52 00
Inhalation Magazine •
Copyright 2018, CSC Publishing Inc. All Rights Reserved • Privacy policy